Is CalciMedica, Inc. (CALC) a Buy, Sell, or Hold?
NASDAQ : CALC
CalciMedica, Inc. — Institutional Ownership
$0.741 USD
-$0.05 (-6.79%)
- Volume
- 229.26K
- Average Volume
- 1.23M
- Market Capitalization
- $11.67M
- P/E Ratio
- -0.56
- Dividend Yield
- 0.00%
- Price Target
- $392.00
- Year High
- $7.20
- Year Low
- $0.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.61
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-20 | CVI Investments, Inc. | 1.56M | 5.10% |
| 2026-07-10 | Christopher D. Alafi | 5.24M | 17.10% |
| 2026-07-10 | Alafi Capital Company LLC | 5.24M | 17.10% |
| 2026-07-02 | Bering Partners II GP, L.L.C. | 2.11M | 6.90% |
| 2026-06-30 | Eric W. Roberts | 1.97M | 6.40% |
| 2026-06-30 | A. Rachel Leheny | 1.93M | 6.30% |
| 2026-06-30 | Valence Investments SPV IV, LLC | 356.99K | 1.20% |
| 2026-06-30 | Valence Investments SPV V, LLC | 86098.0 | 0.30% |
| 2026-06-30 | Valence Investments SPV VI, LLC | 316.11K | 1.00% |
| 2026-06-25 | Avenue Venture Opportunities Fund II, L.P. | 4.64M | 4.99% |
| 2026-05-20 | Chernett Jorey | - | 0.00% |
| 2026-05-08 | Soleus Private Equity Fund III, L.P. | 195.98K | 1.20% |
| 2026-02-06 | Deerfield Mgmt, L.P. | 653.25K | 4.34% |
| 2025-12-01 | Chernett Jorey | 1.13M | 7.90% |
| 2025-11-07 | Soleus Private Equity Fund III, L.P. | 537.93K | 3.80% |
| 2025-10-29 | Bering Partners II, L.P. ("Bering II") | 663.25K | 5.80% |
| 2025-09-09 | Avenue Venture Opportunities Fund II, L.P. | 1.36M | 8.87% |
| 2025-09-02 | Avenue Venture Opportunities Fund II, L.P. | 1.36M | 8.87% |
| 2025-08-05 | Alafi Capital Company, LLC | 1.58M | 11.30% |
| 2025-05-28 | Avenue Venture Opportunities Fund II, L.P. | 1M | 6.70% |
| 2025-05-14 | Stonepine Capital Management, LLC | 628.67K | 4.60% |
| 2025-04-01 | Alafi Capital Company, LLC | 1.3M | 9.60% |
| 2025-03-03 | Aisling Capital V, LP | 781.67K | 3.90% |
| 2025-02-14 | Revelation Healthcare Fund I, L.P. | - | 0.00% |
| 2024-11-26 | Sanderling Ventures VII (Canada), L.P. | 119.71K | 0.90% |
| 2024-11-26 | Sanderling Ventures Management VI | 22899.0 | 0.20% |
| 2024-11-26 | Sanderling Ventures Management VII | 30572.0 | 0.20% |
| 2024-11-26 | Sanderling VI Beteiligungs GmbH & Co KG | 7456.0 | 0.10% |
| 2024-11-26 | Sanderling Ventures Partners VI, L.P. | 968.64K | 7.10% |
| 2024-11-26 | Sanderling Ventures VII Annex Fund, L.P. | 29018.0 | 0.20% |
| 2024-11-26 | Sanderling Ventures VII, L.P. | 455.92K | 3.40% |
| 2024-11-26 | Co-Investment | 838.46K | 6.20% |
| 2024-11-26 | Timothy C. Mills | 2.48M | 17.90% |
| 2024-11-26 | Fred A. Middleton | 2.55M | 18.30% |
| 2024-11-26 | Sanderling VI Limited Partnership | 8884.0 | 0.10% |
| 2024-07-08 | Laurence W. Lytton | 756.18K | 11.00% |
CALC Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6.59 | 15.01B | $98.92B | $11.52M | $9.7M | $98.92B |
| 2024-12-31 | $3.54 | 11.25M | $39.81M | $7.94M | -$ | $31.88M |
| 2023-12-31 | $2.86 | 4.49M | $12.84M | $5.53M | -$ | $7.31M |
| 2022-12-31 | $5.84 | 1.53M | $8.96M | $1.33M | $5.36M | $13M |
| 2021-12-31 | $5.84 | 1.51M | $8.84M | $13.36M | -$ | -$4.52M |
| 2020-12-31 | $5.84 | 472.75K | $2.76M | $33.42M | -$ | -$30.66M |
| 2019-12-31 | $5.84 | 1.03M | $6.03M | $15.87M | $131.36M | $121.53M |
| 2018-12-31 | $5.84 | 857.28K | $5.01M | $12.83M | $78.81M | $70.98M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.54 | 15.01M | $8.11M | $8.16M | -$ | -$57886 |
| 2025-12-31 | $6.59 | 15.01M | $98.92M | $11.52M | $9.7M | $97.1M |
| 2025-09-30 | $3.08 | 15M | $46.19M | $5.47M | $8.9M | $49.62M |
| 2025-06-30 | $1.60 | 15M | $23.99M | $5.92M | $8.5M | $26.57M |
| 2025-03-31 | $1.91 | 14.12M | $26.97M | $12.56M | $8.6M | $23.02M |
| 2024-12-31 | $3.54 | 12.76M | $45.17M | $7.94M | -$ | $37.24M |
| 2024-09-30 | $4.43 | 11.13M | $49.33M | $9.15M | -$ | $40.18M |
| 2024-06-30 | $4.25 | 11.13M | $47.3M | $5.06M | -$ | $42.24M |
| 2024-03-31 | $3.93 | 9.75M | $38.34M | $6.76M | -$ | $31.58M |
| 2023-12-31 | $2.86 | 5.74M | $16.42M | $5.53M | -$ | $10.89M |
| 2023-09-30 | $2.66 | 5.67M | $15.07M | $11.64M | -$ | $3.43M |
| 2023-06-30 | $4.01 | 5.66M | $22.7M | $19.08M | -$ | $3.62M |